HGI
AZN icon

Hansberger Growth Investors’s AstraZeneca AZN Stock Holding History

Hansberger Growth Investors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$3.93M Sell
35,890
-544
-1% -$60.5K 4.46% 10
2020
Q2 		$3.85M Buy
36,434
+4
+0% +$413 4.63% 9
2020
Q1 		$3.25M Buy
36,430
+14,708
+68% +$1.38M 4.39% 11
2019
Q4 		$2.17M Buy
+21,722
New +$2.05M 2.44% 20

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Hansberger Growth Investors's AZN Position: Q3 2020 in Review

Hansberger Growth Investors reduced its AstraZeneca (AZN) stake by 1.5% in Q3 2020, selling an estimated $60.5K and leaving 35,890 shares worth $3.93M. The position accounts for 4.46% of the portfolio, ranked #10.

Hansberger Growth Investors first reported a position in AZN in Q4 2019 and has held it in 4 quarters since. 723 funds tracked by Wall St. Rank hold AZN as of Q3 2020.

  • Hansberger Growth Investors held 35,890 shares of AstraZeneca worth $3.93M as of Q3 2020.
  • Hansberger Growth Investors sold 544 AstraZeneca shares in Q3 2020, an estimated $60.5K.
  • AstraZeneca made up 4.46% of Hansberger Growth Investors's portfolio in Q3 2020, its #10 holding.
  • Hansberger Growth Investors first reported a position in AstraZeneca in Q4 2019 and has held it in 4 quarters since.
  • 723 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2020.

Based on Hansberger Growth Investors's 13F filing for Q3 2020, filed 12 Nov 2020.